G. Taino et al.: Radioprotection 2025, 60( 1), 76 – 83 83 Park SL, Murphy SE, Wilkens LR, Stram DO, Hecht SS, Le Marchand L. 2017. Association of CYP2A6 activity with lung cancer incidence in smokers: the multiethnic cohort study. Plos ONE 12: e0178435.
Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012 May; 21( 3): 308-15. doi: 10.1097 / CEJ. 0 b013e328351e1b6.
Patz EF Jr, Pinsky P, Gatsonis C et al. 2014. Overdiagnosis in lowdose computed tomography screening for lungcancer. JAMA Intern Med 174( 2): 269 – 274.
Peled N, Hakim M Jr, Bunn PA, Miller YE, Kennedy TC, Mattei J, et al. 2012. Non invasive breath analysis of pulmonary nodules. J Thorac Oncol 7: 1528 – 1533.
Phillips M, et al. 2008. Detection of lung cancer using weighted difital analysis of breath biomarkers. Clin Chim Acta 393: 76 – 84.
Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, et al. 1999. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 353: 1930 – 1933.
Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al. 2013. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects( ESCAPE). Lancet Oncol 14( 9): 813 – 822.
Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012 Apr; 67( 4): 296-301. doi: 10.1136 / thoraxjnl-2011- 200736.
Sozzi G, Boeri M, Rossi M, et al. 2014. Clinical utility of a plasmabased miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol 32( 8): 768 – 773.
Taylor R, Najafi F, Dobson A. 2007. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol 36: 1048 – 1059.
UNSCEAR( United Nations Scientific Committee on the Effects of Atomic Radiation). 2009. Effects of Ionising Radiation. UNSCEAR 2006 Report to the General Assembly � Volume II, Annex E: Sources-to-effects assessment for radon in homes and workplaces. New York: United Nations.
Uso M, Jantus-Lewintre E, Sirera R, Bremnes RM, Camps C. 2014. miRNA detection methods and clinical implications in lung cancer. Future Oncol 10( 14): 2279 – 2292. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. de Koning HJ. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009 Dec 3; 361( 23): 2221-9. doi: 10.1056 / NEJMoa0906085.
Wang C et al. 2015. A five-miRNA paneel identified from a multicentric case-control study serves as a novel diagnostic tool for ethnically diverse non small cell lung cancer patients. EBioMedicine 2: 1377 – 1385.
World Health Organization. 2009. WHO Handbook on Indoor Radon: A Public Health Perspective. Geneva, Switzerland: World Health Organization.
Yokota J, Shiraishi K, Kohno T. 2010. Genetic basis for susceptibility to lung cancer: Recent progress and future directions. Adv Cancer Res 109: 51 – 72.
Zhong L, Goldberg MS, Parent ME, Hanley JA. 2000. Exposure to environmental tobacco smoke and the risk of lung cancer: a metaanalysis. Lung Cancer 27: 3 – 18.
Cite this article as: Taino G, Delogu A, Pintucci R, Semborowski L, Oddone E, Osuchowski A, Solazzo F. 2025. Medical surveillance of workers exposed to radon: new perspectives in lung cancer prevention. Radioprotection 60( 1): 76 – 83. https:// doi. org / 10.1051 / radiopro / 2024041
Please help to maintain this journal in open access!
This journal is currently published in open access under the Subscribe to Open model( S2O). We are thankful to our subscribers and supporters for making it possible to publish this journal in open access in the current year, free of charge for authors and readers.
Check with your library that it subscribes to the journal, or consider making a personal donation to the S2O programme by contacting subscribers @ edpsciences. org.
More information, including a list of supporters and financial transparency reports, is available at https:// edpsciences. org / en / subscribe-to-open-s2o.